Saturable binding sites for the coenzyme A ester of nafenopin, a peroxisome proliferator, in rat liver cytosol

References

• Alvares K., Carrillo A., Yuan P. M., Kawano H., Morimoto R. I., Reddy J. K. Identification of cytosolic peroxisome proliferator binding protein as a member of the hear shock protein HSP70 family. Proceedings of the National Academy of Sciences, USA 1990; 87: 5293–5297
   PubMed Web of Science ®Google Scholar
• Bass N. M. The cellular fatty acid binding proteins: aspects of structure, regulation, and function. International Reviews in Cytology 1985; 111: 143–184
   Google Scholar
• Bhuiyan A. K. M. J., Bartlett K., Sherrat H. S., Agius L. Effect of ciprofibrate and 2-[5-(4-chlorophenyl) pentyl] oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters on enzyme activities in rats. Biochemical Journal 1988; 253: 337–343
   PubMed Web of Science ®Google Scholar
• Bronfman M. Possible role of CoASH esters on xenobiotic-induced peroxisomal proliferation and non-genotoxic carcinogenesis. Peroxisomes Biology and Importance in Toxicology and Medicine, G. Gibson, B. Lake. Taylor & Francis, London 1993; 217–245
   Google Scholar
• Bronfman M., Morales M. N., Amigo L., Orellana A., Núñez L., Cárdenas L., Hidalgo P. C. Hypolipidaemic drugs are activated to acyl-CoA esters in isolated rat hepatocytes. Biochemical J. 1992; 284: 289–295
   PubMed Web of Science ®Google Scholar
• Bronfman M., Orellana A., Morales M. N., Bieri F., Waechter F., Staubli W., Bentley P. Potentiation of diacylglicerol-activated protein kinase C by acyl-Coenzyme A thioesters of hypolipidaemic drugs. Biochemical and Biophysical Research Communications 1989; 159: 1026–1031
   PubMed Web of Science ®Google Scholar
• Cann J. R., York E. J., Stewart J. M., Vera J. C., Maccioni R. B. Small zone gel chromatography of interacting systems: theoretical and experimental evaluation of elution profiles for kinetically controlled macromolecule-ligand reactions. Annals of Biochemistry 1988; 175: 462–473
   Google Scholar
• Eacho P. I., Foxworthy P. S., Herron D. K. Tetrazole substituted acetophenone peroxisome proliferators: structure-activity relationships and effects on hepatic metabolism. Peroxisomes Biology and Importance in Toxicology and Medicine, G. Gibson, B. Lake. Taylor & Francis, London 1993; 343–372
   Google Scholar
• Glatz J. F. C., Vander Vusse G. J. Intracellular transport of lipids. Molecular and Cellular Biochemistry 1989; 88: 37–44
   PubMed Web of Science ®Google Scholar
• Glatz J. F. C., Vork M. M., Cistola D. P., Van Der Vusse G. J. Cytoplasmic fatty acid binding protein: significance for intracellular transport of fatty acids and putative role on signal transduction pathways. Prostaglandins Leukotrienes and Essential Fatty Acids 1993; 48: 33–41
   PubMed Web of Science ®Google Scholar
• Guidon P. T., Jr., Hightower L. E. Purification and initial characterization of the 71 kilodaltons heat shock protein and its cognate as fatty acid binding protein. Biochemistry 1986; 25: 3231–3239
   PubMed Web of Science ®Google Scholar
• Hawkins J. M., Jones W. E., Bonner F. W., Gibson G. G. The effect of peroxisomes proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. Drug Metabolism Reviews 1987; 18: 441–515
   PubMed Web of Science ®Google Scholar
• Hertz R., Bar-Tana J. The acylation of proteins by xenobiotic amphipathic carboxylic acids in cultured rat hepatocytes. Biochemical Journal 1988; 254: 39–44
   PubMed Web of Science ®Google Scholar
• Hubbell T., Behnke W. D., Woodford J. K., Schroeder F. Recombinant liver fatty acid binding protein interacts with fatty acyl-Coenzyme A. Biochemistry 1994; 33: 3327–3334
   PubMed Web of Science ®Google Scholar
• Isseman I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature (London) 1990; 347: 645–650
   PubMed Web of Science ®Google Scholar
• Kawaguchi A., Yoshimura T., Okuda S. A new method for the preparation of acyl-CoA thioesters. Journal of Biochemistry (Tokyo) 1981; 89: 337–339
   PubMed Web of Science ®Google Scholar
• Knudsen J., Højrup P., Hansen H. O., Hansen H. F., Roepstorff P. Acyl-CoA binding protein in the rat. Biochemical Journal 1989; 262: 513–519
   PubMed Web of Science ®Google Scholar
• Lalwani N. D. E., Fahl W. E., Reddy J. K. Detection of nafenopin-binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compounds. Biochemical and Biophysical Research Communication 1983; 116: 388–393
   PubMed Web of Science ®Google Scholar
• Lock E. A., Mitchell A. M., Elcombe C. R. Biochemical mechanisms of induction of hepatic peroxisomes proliferation. Annual Reviews in Pharmacology and Toxicology 1989; 29: 145–163
   PubMed Web of Science ®Google Scholar
• Milton M. N., Elcombe C. R., Kass G. E. N., Gibson G. G. Lack of evidence for a hepatic peroxisome proliferator receptor and an explanation for the binding of hypolipidaemic drugs to liver homogenates. Biochemistry and Pharmacology 1988; 37: 793–796
   PubMed Web of Science ®Google Scholar
• Mishkin S., Stein L., Gatmaitan Z., Arias I. M. The binding of fatty acids to cytoplasmic proteins: binding to Z protein in liver and other tissues of the rat. Biochemical and Biophysical Research Communications 1972; 47: 997–1003
   PubMed Web of Science ®Google Scholar
• Mishkin S., Turcotte R. The binding of long chain fatty acid CoA to Z, a cytoplasmic protein present in liver and other tissues of the rat. Biochemical and Biophysical Research Communications 1974; 57: 918–926
   PubMed Web of Science ®Google Scholar
• Mogensen I. B., Schulenberg H., Hansen H. O., Spener F., Knudsen J. A novel acyl-CoA binding protein from bovine liver. Biochemical Journal 1987; 241: 189–192
   PubMed Web of Science ®Google Scholar
• Mannervick B., Danielson U. H. Glutathione transferases-structure and catalytic activity. CRC Critical Reviews in Biochemistry 1988; 23: 283–337
   PubMedGoogle Scholar
• Moody D. E., Reddy J. K., Lake B. G., Popp J. A., Reese D. H. Peroxisome proliferation and nongenotoxic carcinogenesis: commentary on a symposium. Fundamental and Applied Toxicology 1991; 16: 233–248
   PubMed Web of Science ®Google Scholar
• Orellana A., Hidalgo P. C., Morales M. N., Mezzano D., Bronfman M. Palmitoyl-CoA and the acyl-CoA thioester of the carcinogenic peroxisome proliferator ciprofibrate potentiate diacylglicerol-activated protein kinase C by decreasing the phosphatidylserine requirement of the enzyme. European Journal of Biochemistry 1990; 190: 57–61
   PubMedGoogle Scholar
• Orellana A., Holuigue L., Hidalgo P. C., Faundez V., González A., Bronfman M. Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of epidermal-growth-factor receptor in isolated rat hepatocytes. European Journal of Biochemistry 1993; 215: 903–906
   PubMedGoogle Scholar
• Reddy J. F., Azarnoff D. L., Hignite C. E. Hypolipidaemic hepatic peroxisomes proliferators from a novel class of chemical carcinogens. Nature (London) 1980; 283: 397–398
   PubMed Web of Science ®Google Scholar
• Rosendal J., Ertbjerg P., Knudsen J. Characterization of ligand binding to acyl-CoA binding protein. Biochemical Journal 1993; 290: 321–326
   PubMed Web of Science ®Google Scholar
• Sorof S. Modulation of mitogenesis by liver fatty acid binding protein. Cancer and Metastasis Reviews 1994; 13: 317–336
   PubMed Web of Science ®Google Scholar